Delivery Order SPE2DB20D3505-SPE2DB24FU5A7

Award Date 6/24/24
Potential Completion Date 6/25/24
Potential Value $5.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,592.56, is for the delivery of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product, under a firm fixed-price delivery order. The award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,508.31, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, with a completion date of December 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) has an award value of $1,658.24. The contract is for the delivery of fluticasone propionate HFA 110 mcg inhalers, with an ultimate completion date of March 3, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of fluticasone propionate HFA 44 mcg inhalers. The contract has a ceiling value of $2,014.01 and is a firm fixed price delivery order that runs through December 10, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $2,134.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone Prop HFA 44 MCG 10.6GM, a prescription medication. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,351.52, is for the delivery of fluticasone propionate HFA 110 mcg inhalers. The contract is a firm fixed-price delivery order with a completion date of February 25, 2025. This award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award, with ID SPE2DX15D7068|SPE2DX25F2GHM, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,256.84 firm fixed price delivery order is for the supply of Fluticasone Prop HFA 110 MCG 12GM, a prescription medication. The contract has an ultimate completion date of November 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,927.20, is for the supply of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract is a firm fixed-price agreement with a completion date of November 16, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is a delivery order valued at $8,206.19 issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA), is for the delivery of 4,566,167,270 units of Fluticasone Prop HFA 110 MCG 12GM, a respiratory medication, with an ultimate completion date of October 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,023.84, is for the delivery of fluticasone propionate HFA 220 mcg 12 gm inhalers. This is a firm fixed-price delivery order contract with no set-aside designation, meaning it was open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB24FU5A7
    Delivery Order

This federal contract award, valued at $5,158.09, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/17/25, 10:07 AM